Related Articles
Molecular mechanisms of astragaloside‑IV in cancer therapy (Review)
Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway
Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4/NF-κB signaling pathway
Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia‑inducible factor‑1α SUMOylation
Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy